This Article Full Text Full Text (PDF) All Versions of this Article: 101/10/995    most recent CIRCRESAHA.107.159228v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Shimizu, T. Articles by Reidy, M. A. Search for Related Content PubMed PubMed Citation Articles by Shimizu, T. Articles by Reidy, M. A. Related Collections Animal models of human disease Pathophysiology Genetically altered mice Smooth muscle proliferation and differentiation

(Circulation Research. 2007;101:995.)
© 2007 American Heart Association, Inc.

Molecular Medicine

Sphingosine 1-Phosphate Receptor 2 Negatively Regulates Neointimal Formation in Mouse Arteries

Takuya Shimizu^*, Tatsu Nakazawa^*, Aesim Cho, Frank Dastvan, Dustin Shilling, Günter Daum, Michael A. Reidy

From the Department of Pathology (T.S., T.N., A.C., F.D., M.A.R.) and Surgery (D.S., G.D.) University of Washington, Seattle.

Correspondence to Michael Reidy, PhD, Department of Pathology, University of Washington, 815 Mercer St, Seattle, WA 98109. E-mail mar1{at}u.washington.edu

Neointimal lesion formation was induced in sphingosine 1-phosphate (S1P) receptor 2 (S1P₂)-null and wild-type mice by ligation of the left carotid artery. After 28 days, large neointimal lesions developed in S1P₂-null but not in wild-type arteries. This was accompanied with a significant increase in both medial and intimal smooth muscle cell (SMC) replication between days 4 to 28, with only minimal replication in wild-type arteries. S1P₂-null SMCs showed a significant increase in migration when stimulated with S1P alone and together with platelet-derived growth factor, whereas both wild-type and null SMCs migrated equally well to platelet-derived growth factor. S1P increased Rho activation in wild-type but not in S1P₂-null SMCs, and inhibition of Rho activity promoted S1P-induced SMC migration. Plasma S1P levels were similar and did not change after surgery. These results suggest that activation of S1P₂ normally acts to suppress SMC growth in arteries and that S1P is a regulator of neointimal development.

Key Words: sphingosine 1-phosphate receptors • smooth muscle cells • neointima

This article has been cited by other articles:

				G. Daum, A. Grabski, and M.A. Reidy Sphingosine 1-Phosphate: A Regulator of Arterial Lesions Arterioscler Thromb Vasc Biol, October 1, 2009; 29(10): 1439 - 1443. [Abstract] [Full Text] [PDF]

				A. D. Grabski, T. Shimizu, J. Deou, W. M. Mahoney Jr, M. A. Reidy, and G. Daum Sphingosine-1-Phosphate Receptor-2 Regulates Expression of Smooth Muscle Alpha-Actin After Arterial Injury Arterioscler Thromb Vasc Biol, October 1, 2009; 29(10): 1644 - 1650. [Abstract] [Full Text] [PDF]

				A. Skoura and T. Hla Regulation of vascular physiology and pathology by the S1P2 receptor subtype Cardiovasc Res, May 1, 2009; 82(2): 221 - 228. [Abstract] [Full Text] [PDF]

				S.-i. Takashima, N. Sugimoto, N. Takuwa, Y. Okamoto, K. Yoshioka, M. Takamura, S. Takata, S. Kaneko, and Y. Takuwa G12/13 and Gq mediate S1P2-induced inhibition of Rac and migration in vascular smooth muscle in a manner dependent on Rho but not Rho kinase Cardiovasc Res, September 1, 2008; 79(4): 689 - 697. [Abstract] [Full Text] [PDF]

				B. R. Wamhoff, K. R. Lynch, T. L. Macdonald, and G. K. Owens Sphingosine-1-Phosphate Receptor Subtypes Differentially Regulate Smooth Muscle Cell Phenotype Arterioscler Thromb Vasc Biol, August 1, 2008; 28(8): 1454 - 1461. [Abstract] [Full Text] [PDF]

				D. D. Tang and Y. Anfinogenova Physiologic Properties and Regulation of the Actin Cytoskeleton in Vascular Smooth Muscle Journal of Cardiovascular Pharmacology and Therapeutics, June 1, 2008; 13(2): 130 - 140. [Abstract] [PDF]